Advancing Cardiovascular Mortality Trend Analysis: A Machine Learning Approach to Predict Future Health Policy Needs.

Aging Cardiovascular Mortality Forecasting Models Health Policy Planning Machine Learning Public Health Time Series Analysis

Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
22 Aug 2024
Historique:
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 23 8 2024
Statut: ppublish

Résumé

This study investigates the forecasting of cardiovascular mortality trends in Greece's elderly population. Utilizing mortality data from 2001 to 2020, we employ two forecasting models: the Autoregressive Integrated Moving Average (ARIMA) and Facebook's Prophet model. Our study evaluates the efficacy of these models in predicting cardiovascular mortality trends over 2020-2030. The ARIMA model showcased predictive accuracy for the general and male population within the 65-79 age group, whereas the Prophet model provided better forecasts for females in the same age bracket. Our findings emphasize the need for adaptive forecasting tools that accommodate demographic-specific characteristics and highlight the role of advanced statistical methods in health policy planning.

Identifiants

pubmed: 39176930
pii: SHTI240549
doi: 10.3233/SHTI240549
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

868-872

Auteurs

Georgios Feretzakis (G)

School of Science and Technology, Hellenic Open University, Patras, Greece.

Nikolaos Theodorakis (N)

Department of Cardiology, Amalia Fleming General Hospital, Athens, Greece.
65+ Clinic, Amalia Fleming General Hospital, Athens, Greece.
School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Georgia Vamvakou (G)

Department of Cardiology, Amalia Fleming General Hospital, Athens, Greece.
65+ Clinic, Amalia Fleming General Hospital, Athens, Greece.

Christos Hitas (C)

Department of Cardiology, Amalia Fleming General Hospital, Athens, Greece.
65+ Clinic, Amalia Fleming General Hospital, Athens, Greece.

Dimitrios Anagnostou (D)

Department of Cardiology, Amalia Fleming General Hospital, Athens, Greece.
65+ Clinic, Amalia Fleming General Hospital, Athens, Greece.

Sofia Kalantzi (S)

65+ Clinic, Amalia Fleming General Hospital, Athens, Greece.
Department of Internal Medicine, Amalia Fleming General Hospital, Athens, Greece.

Aikaterini Spyridaki (A)

65+ Clinic, Amalia Fleming General Hospital, Athens, Greece.
Department of Internal Medicine, Amalia Fleming General Hospital, Athens, Greece.

Zoi Kollia (Z)

65+ Clinic, Amalia Fleming General Hospital, Athens, Greece.

Michalitsa Christodoulou (M)

65+ Clinic, Amalia Fleming General Hospital, Athens, Greece.

Dimitris Kalles (D)

School of Science and Technology, Hellenic Open University, Patras, Greece.

Andreas F Gkontzis (AF)

School of Science and Technology, Hellenic Open University, Patras, Greece.

Vassilios S Verykios (VS)

School of Science and Technology, Hellenic Open University, Patras, Greece.

Maria Nikolaou (M)

Department of Cardiology, Amalia Fleming General Hospital, Athens, Greece.
65+ Clinic, Amalia Fleming General Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH